INSPPIRE 2 will provide the most comprehensive and reliable estimates to characterize the demographics of the pediatric ARP and CP cohort, presence of family history of acute and chronic pancreatitis, diabetes and pancreatic cancer, disease burden and sequelae, and prthe-official-newsletter-of-the-insppire-studyedictors of early onset CP and its sequelae. The established cohort and biorepository will facilitate subsequent studies, leading to new strategies for diagnosis, methods to monitor disease progression, and treatment of ARP and CP
INSPPIRE 2 newsletters are available in the following archived document list. You can select each one of them to download a copy of your own.
INSPPIRE 2 Spring Newsletter 2022
.pptx
Download PPTX • 1.25MB